This is relevant since several groups have independently pinpointed BDCA-3+ DC (designated cDC1) as mainly responsible for cross-presentation of tumor derived antigens on MHC class I for effective CD8+ cytotoxic T cell priming [36–38]. Here, MPPE1 is linked to neoplasm.